Critical illness

4 trials 3 recruiting MedDRA PT
4 Registered trials
3 Recruiting
4 Unique sponsors
5 Unique IMPs
0 Commercial trials
Drug classes (ATC)
ATC code not specified 2
C Cardiology (ATC C) 1
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 5 substances
Phase III: 2 Phase IV: 2

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase III

2 trials
  • Assistance Publique Hopitaux De Paris Academic
    IMP not specified
    2024-516021-32-00 1 country 2022 n=3,276
    Ended
  • Universita' Degli Studi Di Torino Academic
    NORADRENALINE TARTRATE
    2023-503895-25-00 2 countries 2024 n=320
    Recruiting

Phase IV

2 trials
  • Monash University Academic
    IMP not specified
    2022-501157-36-00 5 countries 2024 n=760
    Recruiting
  • Universitaet Muenster Academic
    MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, MALIC ACID, SODIUM ACETATE TRIHYDRATE; MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, SODIUM ACETATE TRIHYDRATE; POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE; SODIUM CHLORIDE, CALCIUM ACETATE, MAGNESIUM ACETATE TETRAHYDRATE, POTASSIUM ACETATE, SODIUM ACETATE TRIHYDRATE
    2025-523914-10-00 1 country 2026 n=660
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Assistance Publique Hopitaux De Paris Academic 1 Phase III 0
Universita' Degli Studi Di Torino Academic 1 Phase III 1
Monash University Academic 1 Phase IV 1
Universitaet Muenster Academic 1 Phase IV 1
New trials by year
2022
1
2024
2
2026
1
← All indication landscapes